Lumír Kunovský: Pancreas2000 project

Recently Lumír Kunovský, Associate Professor at the University Hospital Brno, shared a post on X about a recent paper by Kasper Overbeek et al. titled “Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment” published in CGH:

Lumír Kunovský commented on X sharing the paper:

“Pancreas2000 project.

• Type 1 Autoimmune Pancreatitis in Europe
• Clinical Profile and Response to Treatment

in Clinical Gastroenterology and Hepatology (CGH)

EPC2024
Date: June 26-29, 2024

Figure 1

Complete remission stratified on elevation of IgG4 level.

Remission stratified for the different steroid remission induction treatment or no treatment.

• Complete remission: absence of clinical symptoms and resolution of radiologic abnormalities attributed to AIP.
• Partial remission: either absence of symptoms or resolution of radiol abnormal.

Conclusions

• Patients with type 1 AIP and elevated IgG4 level may need closer monitoring.
• For remission induction, a starting dose of 0.4 mg/kg/day for 2 weeks followed by a short taper period seems effective.”

Source: Lumír Kunovský/X